{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T11:29:05Z","timestamp":1771932545909,"version":"3.50.1"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>In Thailand, access to specific pharmaceuticals and medical devices for ST-elevation myocardial infarction (STEMI) patients is restricted within certain healthcare systems, leading to inequalities in the quality of medical care among different healthcare systems. This study aims to compare mortality rates within one year of STEMI patients among the public health insurance schemes of Thailand.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methodology<\/jats:title><jats:p>This study is a single-center retrospective analysis of patients with STEMI treated with primary percutaneous coronary intervention (pPCI). It involves patients utilizing various state health insurance schemes in Thailand from January 1, 2010, to December 31, 2020. Data collection occurred through the hospital's computerized management system and the registration administration office of the Department of Provincial Administration.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The study involved 1,077 patients, categorized into three groups based on their state health insurance: Universal Health Coverage (UC) (546 patients, 50.7%), Social Security System (SS) (199 patients, 18.5%), and Civil Service Reimbursement (CS) (332 patients, 30.8%). The one-year mortality rates in these groups were 10.57%, 4.21%, and 6.47%, respectively (<jats:italic>p<\/jats:italic>\u2009=\u20090.010). In the unadjusted model, the SS group showed a lower risk of one-year mortality [Hazard Ratio (HR) 0.38, 95% CI 0.18\u20130.80, <jats:italic>p<\/jats:italic>\u2009=\u20090.011], and the CS group also demonstrated a lower risk (HR 0.59, 95% CI 0.35\u20130.99, <jats:italic>p<\/jats:italic>\u2009=\u20090.047) compared to the UC group. In the adjusted model, only the CS group significantly reduced the risk of one-year mortality. Other factors that affected one-year mortality were age \u226565 years, prior coronary artery diseases, Killip class 3\u20134, pre-discharge prescription of angiotensin-converting enzyme inhibitors, occlusion in the left anterior descending artery, multivessel disease, in-hospital atrial fibrillation\/flutter and in-hospital pericardial effusion.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Healthcare schemes play a significant role in influencing one-year mortality rates among STEMI patients treated with pPCI. This information would be crucial for developing strategies and programs to aid healthcare policymakers at both regional and international levels in reducing morbidity and mortality.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2024.1397015","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T04:46:09Z","timestamp":1728017169000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Mortality rate of percutaneous coronary interventions in ST-segment elevation myocardial infarction patients under the public health insurance schemes of Thailand"],"prefix":"10.3389","volume":"11","author":[{"given":"Suppavit","family":"Chumsantivut","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somrat","family":"Lertmaharit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanapoom","family":"Rattananupong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vorarit","family":"Lertsuwunseri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siriporn","family":"Athisakul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaisiri","family":"Wanlapakorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suphot","family":"Srimahachota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"B2","first-page":"1","article-title":"Demographic, management practices and in-hospital outcomes of Thai acute coronary syndrome registry (TACSR): the difference from the western world","volume":"90","author":"Srimahachota","year":"2007","journal-title":"J Med Assoc Thai"},{"key":"B3","first-page":"508","article-title":"Thai Registry in acute coronary syndrome (TRACS)-an extension of Thai acute coronary syndrome registry (TACS) group: lower in-hospital but still high mortality at one-year","volume":"95","author":"Srimahachota","year":"2012","journal-title":"J Med Assoc Thail"},{"key":"B4","doi-asserted-by":"publisher","first-page":"5839834","DOI":"10.1155\/2022\/5839834","article-title":"Patient characteristics, procedural details, and outcomes of contemporary percutaneous coronary intervention in real-world practice: insights from nationwide Thai PCI registry","volume":"2022","author":"Sansanayudh","year":"2022","journal-title":"J Interv Cardiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jacc.2021.09.005","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0140-6736(03)12113-7","article-title":"Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials","volume":"361","author":"Keeley","year":"2003","journal-title":"Lancet"},{"key":"B8","volume-title":"Regional Office for the Western P. the Kingdom of Thailand Health System Review","year":"2015"},{"key":"B9","doi-asserted-by":"publisher","first-page":"100411","DOI":"10.1016\/j.cpcardiol.2019.02.003","article-title":"Does insurance effect the outcome in patients with acute coronary syndrome?: an insight from the most recent national inpatient sample","volume":"46","author":"Chakraborty","year":"2021","journal-title":"Curr Probl Cardiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ijcme.2014.08.004","article-title":"Mortality in myocardial infarction remains high in Argentina: the association with health insurance coverage","volume":"4","author":"Arazi","year":"2014","journal-title":"IJC Metab Endocr"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.amjcard.2017.06.041","article-title":"Association between health insurance status and in-hospital outcomes after ST-segment elevation myocardial infarction","volume":"120","author":"Pancholy","year":"2017","journal-title":"Am J Cardiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e004971","DOI":"10.1161\/CIRCOUTCOMES.118.004971","article-title":"In-Hospital management and outcomes after ST-segment-elevation myocardial infarction in medicaid beneficiaries compared with privately insured individuals","volume":"12","author":"Patel","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"B13","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S0195-668X(02)00325-1","article-title":"Predictors of 90-day outcome in patients stabilized after acute coronary syndromes","volume":"24","author":"Newby","year":"2003","journal-title":"Eur Heart J"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e000405","DOI":"10.1136\/openhrt-2016-000405","article-title":"Mortality pattern and cause of death in a long-term follow-up of patients with STEMI treated with primary PCI","volume":"3","author":"Hosseiny","year":"2016","journal-title":"Open Heart"},{"key":"B15","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1464-5491.2004.01114.x","article-title":"Hospital outcome of acute myocardial infarction in patients with and without diabetes mellitus","volume":"21","author":"Otter","year":"2004","journal-title":"Diabet Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2337\/diacare.21.1.69","article-title":"Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA myocardial infarction register study group","volume":"21","author":"Miettinen","year":"1998","journal-title":"Diabetes Care"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/0735-1097(95)00299-5","article-title":"Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the \u201csmoker\u2019s paradox\u201d from the GUSTO-I trial, with angiographic insights. Global utilization of streptokinase and tissue-plasminogen activator for occluded coronary arteries","volume":"26","author":"Barbash","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/S0002-9149(01)01457-6","article-title":"Predictive value of the killip classification in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction","volume":"87","author":"DeGeare","year":"2001","journal-title":"Am J Cardiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/joim.13656","article-title":"Elevated low-density lipoprotein cholesterol: an inverse marker of morbidity and mortality in patients with myocardial infarction","volume":"294","author":"Schubert","year":"2023","journal-title":"J Intern Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1136\/heartjnl-2012-302536","article-title":"Symptom onset-to-balloon time and mortality in the first seven years after STEMI treated with primary percutaneous coronary intervention","volume":"98","author":"Rollando","year":"2012","journal-title":"Heart"},{"key":"B21","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.hlc.2014.09.015","article-title":"Shorter ischaemic time and improved survival with pre-hospital STEMI diagnosis and direct transfer for primary PCI","volume":"24","author":"Farshid","year":"2015","journal-title":"Heart Lung Circ"},{"key":"B22","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/ccd.22507","article-title":"A comparative analysis of major clinical outcomes using drug-eluting stents versus bare-metal stents in a large consecutive patient cohort","volume":"76","author":"Bental","year":"2010","journal-title":"Catheter Cardiovasc Interv"},{"key":"B23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1146\/annurev.publhealth.27.021405.102103","article-title":"Health disparities and health equity: concepts and measurement","volume":"27","author":"Braveman","year":"2006","journal-title":"Annu Rev Public Health"},{"key":"B24","doi-asserted-by":"publisher","first-page":"415","DOI":"10.2471\/BLT.18.223693","article-title":"Universal health coverage and primary care, Thailand","volume":"97","author":"Sumriddetchkajorn","year":"2019","journal-title":"Bull World Health Organ"},{"key":"B25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12872-020-01379-3","article-title":"Access to reperfusion therapy and mortality outcomes in patients with ST-segment elevation myocardial infarction under universal health coverage in Thailand","volume":"20","author":"Limwattananon","year":"2020","journal-title":"BMC Cardiovasc Disord"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1397015\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T04:46:11Z","timestamp":1728017171000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1397015\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,4]]},"references-count":25,"alternative-id":["10.3389\/fcvm.2024.1397015"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2024.1397015","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,4]]},"article-number":"1397015"}}